← All organizations
Eulji University
Academic/HospitalWebsite ↗
Also known as: Department of Family medicine, Eulji University Hospital | Department of Urology, Eulji University, College of Medicine | Eulji Central Hospital | Eulji General Hospital | Eulji University Hospital | Nowon Eulji University Hospital | Seoul Eulji Hospital
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2005Last known activity
Oct 15, 2024
Timeline
1960s
- Jan 1, 1967
Eulji University— Founded
Drugs by trial phase (37 distinct, 29 trials)
Phase 4 (21 own, 0 via acquisition)
Phase 3 (14 own, 0 via acquisition)
- chondroitin
- cilnidipine
- entecavir
- tamsulosin
- amlodipine
- mitiglinide
- olmesartan
- allogeneic adipose derived mesenchymal stem cell
- umbilical cord mesenchymal stem cells
- inactivated influenza vaccine
- losartan
- hydrochlorothiazide
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
- Inactivated polio virus - Enhanced
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Arthritis
- Arthritis, Juvenile
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Foot
- Diphtheria
- Essential Hypertension
- Fasciitis
- Fasciitis, Plantar
- Foot Ulcer
- Glomerulonephritis
- Hepatitis
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis C
- Hyperlipidemias
- Hyperlipoproteinemias
- Hyperplasia
- Hypertension
- Influenza, Human
- Joint Diseases
- Kidney Diseases
- Kidney Failure, Chronic
- Osteoarthritis
- Osteoarthritis, Knee
- Osteoporosis
- Poliomyelitis
- Prostatic Hyperplasia
- Prostatic Neoplasms
- Renal Insufficiency
- Spondylitis
- Spondylitis, Ankylosing
- Stroke
- Tetanus
- Ulcer
- Ureteral Calculi
- Ureterolithiasis
- Whooping Cough
Recent trials (35)
- NCT06622603CollaboratorPhase 4Oct 15, 2024
- NCT06590714Lead sponsorN/AAug 23, 2024
- NCT06590714Sponsor investigatorN/AAug 23, 2024
- NCT05718375OfficialPhase 2Jan 25, 2023
- NCT05718375Overall official - principal investigatorPhase 2Jan 25, 2023
- NCT07105319Lead sponsorPhase 4Nov 30, 2021
- NCT07105319Sponsor investigatorPhase 4Nov 30, 2021
- NCT05004324Overall official - principal investigatorPhase 3Jun 29, 2021
- NCT04248621Overall official - principal investigatorPhase 4Jan 23, 2020
- NCT04248621CollaboratorPhase 4Jan 23, 2020
- NCT04618640Study chairPhase 3Dec 26, 2019
- NCT03370874Overall official - principal investigatorPhase 3Jul 4, 2018
- NCT03357653CollaboratorPhase 3Jan 30, 2018
- NCT03020628Overall official - principal investigatorPhase 3Oct 1, 2016
- NCT02580474CollaboratorPhase 4Feb 1, 2016
Details
- Founded
- Seongnam City, KR Jan 1, 1967
- Last known activity
- Oct 15, 2024